The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction

Study Overview
=================
Brief Summary
-----------------
This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.

Detailed Description
-----------------
The PanOptix trifocal lens by Alcon was introduced in 2015 and is currently in use in over 70 countries. Its outcomes on the AcrySof platform are well documented and highly appealing to patients and clinicians.,, Clinicians no longer need to routinely target monovision or modified monovision to provide a range of vision. With the release of the Clareon material for this lens, questions remain about how the new lens material will influence patient satisfaction and uncorrected visual performance.

Official Title
-----------------
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance

Conditions
-----------------
Cataract

Intervention / Treatment
-----------------
* Device: PanOptix or PanOptix Toric IOL


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with cataract and otherwise healthy eyes, not exhibiting any significant ocular morbidity that would be expected to influence outcome measures. Patients implanted with Clareon PanOptix or Clareon Panoptix Toric lenses bilaterally within 6 months of the survey administration. Exclusion Criteria: Patients with visually significant comorbidities (corneal, retina, optic nerve disease) that could affect their satisfaction with surgery Patients with surgical complications either during or after surgery (capsule tears, iris trauma, decentered IOL, cystoid macular edema, etc.) Patients with previous refractive surgery within the past 6 months prior to cataract surgery Patients with > grade 1 posterior capsule opacity at their last visit

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Device: PanOptix or PanOptix Toric IOL|Patients who previously underwent cataract surgery with the PanOptix or PanOptix Toric IOL in both eyes.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of patients reporting not at all or just a little when asked, With or without glasses, how much do you notice glare or haloes around lights in dim light situations? | Percentage of patients who notice glare or haloes around lights in dim light situations | Up to 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of postoperative patients who report rarely when asked How often do you need glasses to see the computer? | How often do you need glasses to see the computer. | Up to 6 months | 
| Percentage of postop patients who report they do not require reading glasses for various activities when asked For what types of activities do you need glasses to see (other than sunglasses)? | Percentage of postoperative patients who report that they do not require glasses for varous activities. | Up to 6 months |